AKT1 and cervical carcinoma: In addition, Xu et al. have demonstrated that the alterations in the PI3K-AKT pathway are prevalent in cervical cancer, which may partially explain the promising effectiveness of this combination therapy in cervical cancer.13 The mechanisms underlying the combination therapy in cervical cancer warrant further investigation.